By API User
About us: Save Our Sons Duchenne Foundation was founded in 2008 and is the peak body for those living with Duchenne and Becker muscular dystrophy (around 1,000 young people) across Australia. Our vision is to find a cure for Duchenne and Becker muscular dystrophy whilst actively working to ensure enhanced quality of life (including quality … Continued
By API User
Highlights• Philips will add CT:VQ™ to its North American product catalogue, backed by minimum contractual order commitment of approximately A$15m (US$10m) over two years • CT:VQ™ sales via Philips will be on full commercial terms • Philips to deploy dedicated sales and clinical specialists with CT:VQ™ targets across United States and Canada • Commercial launch … Continued
By API User
3 December 2025 – Perth, Australia | Nexsen Limited (ASX:NXN) has today announced the appointment of internationally recognised surgeon-scientist, Professor Shekhar Kumta, as a Non-Executive Director. Professor Kumta brings more than 45 years’ experience across Australia and Hong Kong, with senior faculty, hospital governance and medical leadership roles spanning major institutions including the Chinese University … Continued
By API User
The Royal Australian College of GPs (RACGP) is calling for the Federal Government to improve support for longer consultations and home visits, in line with the goals of the 2025 International Day of People with Disability. This year’s theme focuses on “fostering disability inclusive societies for advancing social progress”. The Department of Health, Disability and Ageing also released documentation covering the theme, which suggests a range … Continued
By API User
3 December 2025 – Melbourne, Australia | LTR Pharma Limited (ASX:LTP) has today announced it has received Human Research Ethics Committee (HREC) approval from Bellberry (NHMRC-certified) for its SPONTAN® Phase II pharmacokinetic and multiple-dose clinical study, paving the way for recruitment to commence in Q1 calendar year 2026. The Phase II study has been designed … Continued
By API User
Scientists in Melbourne have discovered how tiny electrical pulses can steer stem cells as they grow, opening the door to new improved ways of creating new tissues, organs, nerves and bones. Dr Amy Gelmi, a Senior Lecturer at RMIT University’s School of Science, led the work using advanced atomic force microscopy to track how stem … Continued
By API User
A new Monash University study has found that child maltreatment costs Australia $21.6 billion in annual health service use costs and $24.1 billion in annual lost productivity. According to the World Health Organization, child maltreatment involves physical abuse, sexual abuse, emotional abuse, neglect and exposure to domestic violence. The new analysis used information from the … Continued
By API User
New accessible resources aim to make it easier for people with dementia and their families to access dementia-friendly eyecare. People living with dementia are more likely to experience treatable sight problems, which could be prevented through simple interventions such as updating or replacing spectacles, or cataract surgery. Poor eyesight makes living with dementia … Continued
By API User
Clinical development of 212Pb-ADVC001 (ADVC001) is advancing rapidly with encouraging Phase 1b data presented at ESMO 2025 The Phase 2 expansion will evaluate 160 MBq and 200 MBq doses of ADVC001 using a randomized, multi-dose-response design and adaptive dosing strategies to optimize clinical outcomes across three indications: metastatic hormone-sensitive prostate cancer (mHSPC) and metastatic castration-resistant … Continued
By API User
Phase 1 results show that SUL-238 is safe, well-tolerated, and demonstrates favorable pharmacokinetics with high CSF penetration in healthy elderly volunteers, supporting its advancement into further clinical development for Alzheimer’s and other neurodegenerative diseases. ANKARA, TR / ACCESS Newswire / December 2, 2025 / GEN Pharmaceuticals (GENIL.IS), Türkiye’s leading specialty pharmaceutical company, has announced new … Continued
